The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Open accessAbstract
Glioblastomas are lethal cancers characterized by florid angiogenesis promoted in part by glioma stem cells (GSCs). Because hypoxia regulates angiogenesis, we examined hypoxic responses in GSCs. We now demonstrate that hypoxia-inducible factor HIF2alpha and multiple HIF-regulated genes are preferentially expressed in GSCs in comparison to non-stem tumor cells and normal neural progenitors. In tumor specimens, HIF2alpha colocalizes with cancer stem cell markers. Targeting HIFs in GSCs inhibits self-renewal, proliferation, and survival in vitro, and attenuates tumor initiation potential of GSCs in vivo. Analysis of a molecular database reveals that HIF2A expression correlates with poor glioma patient survival. Our results demonstrate that GSCs differentially respond to hypoxia with distinct HIF induction patterns, and HIF2alpha might represent a promising target for antiglioblastoma therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since HIF-2α is strongly expressed in the cytoplasm of NB tumor cells at physiological oxygen levels (5% O2), this could suggest additional largely unexplored functions of HIF-2α in the cytoplasm, independent of HIF-1β-dependent transcription, such as regulation of mRNA translation [9,43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In NB clinical specimens, HIF-1α expression negatively correlates with the presence of blood vessels indicating that HIF-1α is expressed exclusively in hypoxic cells [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, HIF-2α is located in dense clusters of cells adjacent to blood vessels, referred to as the perivascular niche, which have a neural crest-like phenotype, and are HIF-1α negative, suggesting they are not hypoxic [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, treatment with PT2385 had no effect on tumor growth, did not impact transcription of HIF target genes and did not modulate chemotherapy response [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis69,70”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [70]
In the citing paper
“Hypoxia was first shown to induce the CSC phenotype in glioma [77] and, subsequently, in breast cancer [78, 79], in a HIF-dependent manner.”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
Self-citationHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., Vitis, S. D., Fiocco, R., Foroni, C., DiMeco, F., & Vescovi, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D. K., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,844
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M. D., Geschwind, D. H., Bronner-Fraser, M. E., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,842
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,000
Wang, P., Wan, W., Xiong, S., Wang, J., Zou, D., Lan, C., Yu, S., Liao, B., Feng, H., & Wu, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-06086-2 · Cited by 40
Bordji, K., Grandval, A., Cuhna-Alves, L., Lechapt, E., & Bernaudin, M. (2014) · FEBS Journal · doi:10.1111/febs.13062 · Cited by 39
Sgubin, D., Wakimoto, H., Kanai, R., Rabkin, S. D., & Martuza, R. L. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0035 · Cited by 39
Association of NRF2 with HIF-2α-induced cancer stem cell phenotypes in chronic hypoxic condition
Hallis, S. P., Kim, S. K., Lee, J., & Kwak, M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102632 · Cited by 38
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
Alama, A., Orengo, A. M., Ferrini, S., & Gangemi, R. M. R. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.005 · Cited by 38
Kaur, G., Cholia, R. P., Mantha, A. K., & Kumar, R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500865u · Cited by 38
HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia
Abdul-Aziz, A. M., Shafat, M. S., Sun, Y., Marlein, C. R., Piddock, R. E., Robinson, S. D., Edwards, D. R., Zhou, Z., Collins, A., Bowles, K. M., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0151-1 · Cited by 38
Xu, X., Bao, Y., Wang, X., Yan, F., Guo, S., Ma, Y., Xu, D., Li, J., Xu, J., & Wang, J. (2018) · The FASEB Journal · doi:10.1096/fj.201700715 · Cited by 38
Persson, C. U., von Stedingk, K., Fredlund, E., Bexell, D., Påhlman, S., Wigerup, C., & Mohlin, S. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111845 · Cited by 37
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Gupta, I., Hussein, O., Sastry, K. S., Bougarn, S., Gopinath, N., Chin-Smith, E. C., Sinha, Y., Korashy, H. M., & Maccalli, C. (2023) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2023.100107 · Cited by 39
Scott, J. G., Hjelmeland, A. B., Chinnaiyan, P., Anderson, A. R. A., & Basanta, D. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003433 · Cited by 37
Self-citationKarsy, M. J., Guan, J., Jensen, R. L., Huang, E. L., & Colman, H. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.12.032 · Cited by 40
Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype
Munthe, S., Petterson, S. A., Dahlrot, R. H., Poulsen, F. R., Hansen, S., & Kristensen, B. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155106 · Cited by 37
Potential application of cell reprogramming techniques for cancer research
Saito, S., Lin, Y., Nakamura, Y., Eckner, R., Wuputra, K., Kuo, K., Lin, C., & Yokoyama, K. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2924-7 · Cited by 38
Mashiko, R., Takano, S., Ishikawa, E., Yamamoto, T., Nakai, K., & Matsumura, A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0292-8 · Cited by 37
Development and Maintenance of Cancer Stem Cells under Chronic Inflammation
Tanno, T., & Matsui, W. H. (2011) · Journal of Nippon Medical School · doi:10.1272/jnms.78.138 · Cited by 39
Comparative transcriptomics reveals similarities and differences between astrocytoma grades
Seifert, M., Garbe, M., Friedrich, B., Mittelbronn, M. G. A., & Klink, B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1939-9 · Cited by 38
Lai, Y., Tsai, J.-C., Tseng, Y.-T., Wu, M.-S., Liu, W.-S., Lam, H.-I., Yu, J.-H., Nozell, S. E., & Benveniste, E. N. (2017) · Oncotarget · doi:10.18632/oncotarget.14949 · Cited by 37
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
Mao, X., Wang, C., Liu, D.-Y., Zhang, X., Wang, L., Yan, M., Zhang, W., Zhu, J., Li, Z., Mi, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10029 · Cited by 38
Self-citationIvey, J. W., Wasson, E. M., Alinezhadbalalami, N., Kanitkar, A., Debinski, W., Sheng, Z., Davalos, R. V., & Verbridge, S. S. (2019) · Research · doi:10.34133/2019/8081315 · Cited by 39
Valtorta, S., Salvatore, D., Rainone, P., Belloli, S., Bertoli, G. R., & Moresco, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165631 · Cited by 37
Datta, S., Sears, T. K., Cortopassi, G. A., Woolard, K., & Angelastro, J. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111058 · Cited by 36
Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Qiu, Q., Ding, X., Chen, J., Chen, S., & Wang, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.016 · Cited by 37
Crossing the barrier: treatment of brain tumors using nanochain particles
Karathanasis, E., & Ghaghada, K. B. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1387 · Cited by 36
Burko, P., D’Amico, G., Miltykh, I. S., Scalia, F., de Macario, E. C., Macario, A. J. L., Giglia, G., Cappello, F., & Bavisotto, C. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054883 · Cited by 37
Hamidian, A., von Stedingk, K., Thorén, M. M., Mohlin, S., & Påhlman, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.083 · Cited by 37
Effects of surgery on the cancer stem cell niche
O’Leary, D., O'Leary, E., Foley, N., Cotter, T. G., Wang, J. H., & Redmond, H. P. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2015.12.008 · Cited by 36
The changing paradigm of tumour response to irradiation
Hill, R. P. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160474 · Cited by 38
Kitajima, S., Lee, K. L., Fujioka, M., Sun, W., You, J., Chia, G. S., Wanibuchi, H., Tomita, S., Araki, M., Kato, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24919 · Cited by 35
The Organoid Era Permits the Development of New Applications to Study Glioblastoma
Andreatta, F., Beccaceci, G., Fortuna, N., Celotti, M., Felice, D. D., Lorenzoni, M., Foletto, V., Genovesi, S., Rubert, J., & Alaimo, A. (2020) · Cancers · doi:10.3390/cancers12113303 · Cited by 36
Hypoxia-Induced Reactivity of Tumor-Associated Astrocytes Affects Glioma Cell Properties
Pantazopoulou, V., Jeannot, P., Rosberg, R., Berg, T. J., & Pietras, A. (2021) · Cells · doi:10.3390/cells10030613 · Cited by 35
An immunomodulatory bioink with hollow manganese silicate nanospheres for angiogenesis
Wu, J., Chen, Q., Ma, J., Zhang, H., Chang, J., Mao, L., & Wu, C. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101015 · Cited by 35
Lyu, C., Niu, Y., Lai, W., Wang, Y., Wang, Y., Dai, P., Ma, C., Chen, S., Li, Y., Jiang, G., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00399-x · Cited by 35
Self-citationSpina, R., Mills, I., Ahmad, F., Chen, C., Ames, H. M., Winkles, J. A., Woodworth, G. F., & Bar, E. E. (2022) · Oncogene · doi:10.1038/s41388-022-02517-1 · Cited by 35
Liu, H., Han, D., Liu, Y., Hou, X., Wu, J., Li, H., Yang, J., Shen, C., Yang, G., Fu, C., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1034-x · Cited by 35
van Neerven, S. M., Tieken, M., Vermeulen, L., & Bijlsma, M. F. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1098791 · Cited by 37
Yin, T., He, S., Shen, G., & Wang, Y. (2015) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504014x13983417587366 · Cited by 35
Bielecka, A., Lesiak, M., Ludyga, T., Sieroń, A. L., & Obuchowicz, E. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3329-2 · Cited by 35
Khan, Z. M., Munson, J. M., Long, T. E., Vlaisavljevich, E., & Verbridge, S. S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300671 · Cited by 37
Cancer stem cells in glioma: challenges and opportunities.
Wang, J., Ma, Y., & Cooper, M. K. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.01 · Cited by 35
Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?
Lathia, J. D., Venere, M., Rao, M. S., & Rich, J. N. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9194-6 · Cited by 34
Self-citationMicroRNA—A Tumor Trojan Horse for Tumor-Associated Macrophages
Syed, S. N., Frank, A.-C., Raue, R., & Brüne, B. (2019) · Cells · doi:10.3390/cells8121482 · Cited by 37
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
Gaete, D., Rodriguez, D., Watts, D., Sormendi, S., Chavakis, T., & Wielockx, B. (2021) · Cancers · doi:10.3390/cancers13050988 · Cited by 35
Shah, N., Hallur, P. M., Ganesh, R. A., Sonpatki, P., Naik, D., Chandrachari, K. P., Puchalski, R. B., & Chaubey, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-97059-z · Cited by 37
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
Mughal, A. A., Grieg, Z., Skjellegrind, H. K., Fayzullin, A., Lamkhannat, M., Joel, M., Ahmed, M. S., Murrell, W. G., Vik-Mo, E. O., Langmoen, I. A., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0432-z · Cited by 36
Yao, J., Geng, P., Li, Y., Chen, H., Li, J., & Zhu, Y. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s81393 · Cited by 34
El-Badawy, A., Ghoneim, M. A., Gabr, M. M., Salah, R. A., Mohamed, I. K., Amer, M., & El‐Badri, N. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0709-9 · Cited by 34
3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research
Antonelli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310620 · Cited by 34
The hidden architects of glioblastoma multiforme: Glioma stem cells
Sahoo, O. S., Mitra, R., & Nagaiah, N. K. H. (2024) · MedComm – Oncology · doi:10.1002/mog2.66 · Cited by 33
Chen, D., Le, S. B., Ghiaseddin, A. P., Manektalia, H., Li, M., O’Dell, A., Rahman, M., & Tran, D. D. (2025) · Med · doi:10.1016/j.medj.2025.100708 · Cited by 33
Zhang, G., Zhang, Y., Cheng, S., Wu, Z., Liu, F., & Zhang, J. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2566-x · Cited by 35
Revealing the glioma cancer stem cell interactome, one niche at a time
Silver, D. J., & Lathia, J. D. (2017) · The Journal of Pathology · doi:10.1002/path.5024 · Cited by 35
Self-citationSERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types
Lee, N.-H., Park, S.-R., Lee, J. W., Lim, S., Lee, S., Nam, S., Kim, D. Y., Hah, S. Y., Hong, I., & Lee, H. (2019) · Cancers · doi:10.3390/cancers11040499 · Cited by 34
Wang, H., Ye, X., Ju, Y., Cai, Z., Wang, X., Du, P., Zhang, M., Li, Y., & Cai, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247836 · Cited by 33
Self-citationMetabolic Targeting of Cancer Stem Cells
Mukha, A., & Dubrovska, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.537930 · Cited by 33
HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100011 · Cited by 34
C ripto‐1 Expression in Glioblastoma Multiforme
Pilgaard, L., Mortensen, J. H., Henriksen, M., Olesen, P., Sørensen, P., Laursen, R. J., Vyberg, M., Agger, R., Zachar, V., Moos, T., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12131 · Cited by 33
Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication
Iwadate, Y. (2017) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2017-0089 · Cited by 33
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 34
Begagić, E., Bečulić, H., Džidić-Krivić, A., Vukas, S. K., Hadžić, S., Mekić–Abazović, A., Šegalo, S., Papić, E., Muchai, E., Pugonja, R., et al. (2024) · Cancers · doi:10.3390/cancers16112089 · Cited by 33
Targeting drug resistance in glioblastoma (Review)
Sherman, J. H., Bobak, A., Arsiwala, T. A., Lockman, P. R., & Aulakh, S. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5668 · Cited by 34
Zhang, J., Hao, G., Yao, C., Hu, S., Hu, C., & Zhang, B. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00834h · Cited by 32
Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network
Kingsbury, T. J., Kim, M.-J., & Civin, C. I. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.001 · Cited by 32
Targeting Immunometabolism in Glioblastoma
Mohan, A. A., Tomaszewski, W. H., Haskell-Mendoza, A. P., Hotchkiss, K. M., Singh, K., Reedy, J. L., Fecci, P. E., Sampson, J. H., & Khasraw, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696402 · Cited by 34
Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells
Mandhair, H. K., Novak, U., & Radpour, R. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i6.542 · Cited by 32
Byun, J.-Y., Huang, K., Lee, J. S., Huang, W., Hu, L., Zheng, X., Tang, X., Li, F., Jo, D., Song, X., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02166-w · Cited by 33
RetractedGlioblastoma Vasculature: From its Critical Role in Tumor Survival to Relevant in Vitro Modelling
Pacheco, C., Martins, C., Monteiro, J., Baltazar, F., Costa, B. M., & Sarmento, B. F. C. C. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.823412 · Cited by 33
Silver, A., Feier, D., Ghosh, T., Rahman, M., Huang, J., Sarkisian, M. R., & Deleyrolle, L. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022716 · Cited by 36
Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells
Chang, C. K., Edin, N. F. J., Lauritzen, K. H., Aspmodal, I., Mikalsen, S. G., Liu, J., Rasmussen, L. J., Pettersen, E. O., Xiaoqun, G., & Bergersen, L. H. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0081-9 · Cited by 32
Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma
Zhu, J., Wang, H., Ji, X., Zhu, L., Sun, Q., Cong, Z., Zhou, Y., Liu, H., & Zhou, M. (2013) · Oncology Letters · doi:10.3892/ol.2013.1760 · Cited by 32
Self-citationLinking differential radiation responses to glioma heterogeneity
Ke, C., Tran, K. K., Chen, Y., Donato, A. T. D., Yu, L., Hu, Y., Linskey, M. E., Wang, P. H., Limoli, C. L., & Zhou, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.1823 · Cited by 32
Liu, T. T., Achrol, A. S., Mitchell, L. A., Du, W. A., Loya, J. J., Rodriguez, S., Feroze, A. H., Westbroek, E. M., Yeom, K. W., Stuart, J. M., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4631 · Cited by 32
Luan, Y., Gao, C., Miao, Y., Li, Y., Wang, Z., & Qiu, X. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2012.10.017 · Cited by 31
Untuning the tumor metabolic machine: HIF-α: pro- and antitumorigenic?
Young, R. M., & Simon, M. C. (2012) · Nature Medicine · doi:10.1038/nm.2865 · Cited by 31
Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage
Mohlin, S., Wigerup, C., & Påhlman, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.002 · Cited by 31
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter
Longo, S. L., Griffith, C. C., Glass, A. M., Shillitoe, E. J., & Post, D. E. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.62 · Cited by 32
Revuelta, M., Arteaga, O., Montalvo, H., Alvarez, A. A., Hilario, E., & Martínez-Ibargüen, A. (2015) · Brain Pathology · doi:10.1111/bpa.12272 · Cited by 31
Xu, M., Lu, Q., Song, Y., Yang, L., Ren, C., Li, W., Liu, P., Wang, Y., Zhu, Y., & Li, N. (2020) · Nano Research · doi:10.1007/s12274-020-2818-5 · Cited by 31
Voss, D. M., Sloan, A. R., Spina, R., Ames, H. M., & Bar, E. E. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1233 · Cited by 31
Therapeutic Targeting of Cancer Stem Cells
Maugeri‐Saccà, M., Zeuner, A., & Maria, R. D. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00010 · Cited by 31
Phage display discovery of novel molecular targets in glioblastoma-initiating cells
Liu, J. K., Lubelski, D., Schonberg, D. L., Wu, Q., Hale, J. S., Flavahan, W. A., Mulkearns-Hubert, E. E., Man, J., Hjelmeland, A. B., Yu, J. J., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.65 · Cited by 31
Self-citationSuperior Efficacy of Tumor Cell Vaccines Grown in Physiologic Oxygen
Olin, M. R., Andersen, B. M., Zellmer, D. M., Grogan, P. T., Popescu, F. E., Xiong, Z., Forster, C. L., Seiler, C., SantaCruz, K. S., Chen, W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1572 · Cited by 31
Biomimetic models to examine microenvironmental regulation of glioblastoma stem cells
Nakod, P. S., Kim, Y., & Rao, S. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.007 · Cited by 31
Chen, L., Qi, Q., Jiang, X., Wu, J., Li, Y., Liu, Z., Cai, Y., Ran, H., Zhang, S., Zhang, C., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1348 · Cited by 30
Vageli, D. P., Doukas, P. G., Goupou, K., Benos, A. D., Astara, K., Zacharouli, K., Sotiriou, S., & Ιωάννου, Μ. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.052130 · Cited by 34
HIF‐1α and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line
Mo, J., Choi, I. J., Jeong, W., Jeon, E.-H., & Ahn, S. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02181.x · Cited by 30
Disparities in Brain Cancer in the United States: A Literature Review of Gliomas
Persaud-Sharma, D., Burns, J., Trangle, J., & Moulik, S. (2017) · Medical Sciences · doi:10.3390/medsci5030016 · Cited by 30
Saccà, C. D., Gorini, F., Ambrosio, S., Amente, S., Faicchia, D., Matarese, G., Lania, L., & Majello, B. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.03.004 · Cited by 30
SOD2 acetylation and deacetylation: Another tale of Jekyll and Hyde in cancer
Hjelmeland, A. B., & Patel, R. P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916214116 · Cited by 30
Self-citationFuchs, Q., Pierrevelcin, M., Messé, M., Lhermitte, B., Blandin, A.-F., Papin, C., Coca, A. H., Dontenwill, M., & Entz‐Werlé, N. (2020) · Cancers · doi:10.3390/cancers12040979 · Cited by 31
Hale, J. S., Li, M., Sinyuk, M., Jahnen‐Dechent, W., Lathia, J. D., & Silverstein, R. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040033 · Cited by 31
Self-citationKoh, L., Koh, G. R. H., Ng, F. S.-L., Toh, T. B., Sandanaraj, E., Chong, Y. K., Phong, M., Tucker‐Kellogg, G., Kon, O. L., Ng, W. H., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4999 · Cited by 30
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells
Daniele, S., Pietrobono, D., Costa, B., Giustiniano, M., Pietra, V. L., Giacomelli, C., Regina, G. L., Silvestri, R., Taliani, S., Trincavelli, M. L., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00023 · Cited by 31
The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies
Singh, V. K., Saini, A., & Chandra, R. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00052 · Cited by 30
Exploiting S-nitrosylation for cancer therapy: facts and perspectives
Rizza, S., & Filomeni, G. (2020) · Biochemical Journal · doi:10.1042/bcj20200064 · Cited by 31
At the crossroads of cancer stem cells and targeted therapy resistance
Wang, A., Qu, L., & Wang, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.039 · Cited by 31
Helical Self‐Assembly of Optically Active Glycoconjugated Phthalocyanine J‐Aggregates
Bächle, F., Maichle‐Mößmer, C., & Ziegler, T. (2019) · ChemPlusChem · doi:10.1002/cplu.201900381 · Cited by 29
Glioblastoma Stem Cells: A Neuropathologist's View
McLendon, R. E., & Rich, J. N. (2010) · Journal of Oncology · doi:10.1155/2011/397195 · Cited by 29
Self-citationBulnes, S., Bengoetxea, H., Ortuzar, N., Argandoña, E., García-Blanco, A., Rico‐Barrio, I., & Lafuente, J. V. (2012) · Journal of Signal Transduction · doi:10.1155/2012/597915 · Cited by 30
Metadata
- Authors
- Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N.
- Affiliations
- Duke Medical Center (US)
- Cleveland Clinic (US)
- Corresponding author
- Rich, Jeremy N.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 15
- Issue
- 6
- Pages
- 501-513
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2693960
- OpenAlex
- W2039075677
- Cited by
- 1,354
- References
- 65
- Citations by year
- 2026: 41 · 2025: 40 · 2024: 49 · 2023: 72 · 2022: 92 · 2021: 98 · 2020: 72 · 2019: 75 · 2018: 74 · 2017: 93 · 2016: 97 · 2015: 97 · 2014: 96 · 2013: 80 · 2012: 101
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 116659, R01CA116659, CA112958, R01CA129958)
- National Institute of Neurological Disorders and Stroke (K02NS047409, R01NS054276, NS054276, NS047409)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- HIF-2α, glioma stem cells, glioblastoma, hypoxia, angiogenesis, self-renewal, tumor initiation, cancer stem cell markers, patient survival, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Brain Neoplasms, Cell Survival, Cells, Cultured, Glioblastoma, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Stem Cells, Biomarkers, Tumor, Neoplastic Stem Cells, Cell Hypoxia, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
